News & Events zu LeonaBio Inc (LONA)

$7.940

+0.050 (+0.63%)Zum Schluss

LONA-News

8.508-12Newsfilter

LeonaBio to Present Lasofoxifene at Breast Cancer Summit

9.505-07seekingalpha

Athira Pharma Q1 Earnings Beat Expectations

9.505-07seekingalpha

Athira Pharma Q1 Earnings Beat Expectations

5.005-07Newsfilter

LeonaBio Appoints New Board Members to Drive Growth

9.503-27seekingalpha

LeonaBio Reports FY 2025 Financial Results

8.503-26Newsfilter

LeonaBio Secures License for Lasofoxifene Development Program

9.003-26moomoo

LEONABIO INC ANTICIPATES COMPLETION OF PHASE 3 LASOFOXIFENE TRIAL ENROLLMENT BY Q4 2026, WITH TOPLINE RESULTS EXPECTED IN SECOND HALF OF 2027

4.002-19moomoo

LEONABIO INC: MIZUHO UPGRADES RATING TO OUTPERFORM AND INCREASES TARGET PRICE TO $10 FROM $4

Mehr News anzeigen

LONA-Events

2/3 07:10

LeonaBio Appoints Mark Kubik as Chief Business Officer

LeonaBio announced the appointment of Mark Kubik as Chief Business Officer. Kubik previously served as a strategic consultant to LeonaBio.

1/20 16:50

LeonaBio Files to Sell 5.5M Shares of Common Stock

LeonaBio files to sell 5.5M shares of common stock for holders

Mehr Events anzeigen

Diese Seite dient nur der Recherche und ist keine Anlageberatung. Modelle können falsch liegen. Vergangene Wertentwicklung ist kein Indikator für die Zukunft.